Positive association between insight and attitudes toward medication in Japanese patients with schizophrenia: Evaluation with the Schedule for Assessment of Insight (SAI) and the Drug Attitude Inventory - 10 Questionnaire (DAI-10)

Psychiatry Clin Neurosci. 2021 May;75(5):187-188. doi: 10.1111/pcn.13215. Epub 2021 Mar 31.

Satsuki Ito^{1

2}, Junya Matsumoto², Yoshie Sakai^{2

3}, Kenichiro Miura², Naomi Hasegawa², Hidenaga Yamamori^{2

4

5}, Keiichiro Ishimaru^{2

6}, Yoshiharu Kim⁷, Ryota Hashimoto^{2

5}

¹ Department of Developmental and Clinical Psychology, The Division of Human Developmental Sciences, Graduate School of Humanity and Sciences, Ochanomizu University, Tokyo, Japan.
² Department of Pathology of Mental Diseases, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.
³ Department of Clinical Psychology, Atomi University, Tokyo, Japan.
⁴ Japan Community Health Care Organization Osaka Hospital, Osaka, Japan.
⁵ Department of Psychiatry, Osaka University Graduate School of Medicine, Osaka, Japan.
⁶ Faculty of Core Research, Ochanomizu University, Tokyo, Japan.
⁷ National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

No abstract available

Publication types